Dragan Cicic

Title: Dragan Cicic - Innovator in Hematologic Cancer Treatments

Introduction

Dragan Cicic is a prominent inventor based in Brooklyn, NY, known for his significant contributions to the field of cancer treatment. With a total of five patents to his name, Dragan has focused on developing innovative methods for treating hematologic malignancies, showcasing his dedication to improving patient outcomes.

Latest Patents

Dragan's latest patents include groundbreaking methods for treating hematologic malignancies. One notable invention is a low dose antibody-based method that targets hematologic malignancy-associated antigens. This method is designed for subjects with varying levels of peripheral cancerous cell burden, providing tailored treatment options. Another significant patent involves the use of a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic, which aims to enhance the effectiveness of cancer treatment by inducing cancer cell death.

Career Highlights

Throughout his career, Dragan has made substantial strides in cancer research and treatment methodologies. His work has been instrumental in advancing the understanding of hematologic malignancies and developing targeted therapies that improve patient care.

Collaborations

Dragan has collaborated with notable companies in the pharmaceutical industry, including Actinium Pharmaceuticals, Limited and Actinium Pharmaceuticals, Inc. These partnerships have allowed him to leverage resources and expertise to further his innovative research in cancer treatment.

Conclusion

Dragan Cicic's